Delivery Order SPE2DB22D3301-SPE2DB24FY4QE
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $45,168.10 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,916.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $5,121.37 order has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $3,597.61 contract has a period of performance through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have any set-aside designations. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,014.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of XELJANZ XR 11 MG TABLET UU 30S. The award, valued at $2,793.81, has a completion date of February 20, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,086.77 firm fixed price delivery order contract to provide XELJANZ 5 MG TABLET UU 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,110,984 units of the pharmaceutical drug XELJANZ XR 11 MG TABLET. The contract has a ceiling value of $5,377.94 and a period of performance through March 29, 2024. This order is a part of AmerisourceBergen's indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ 10 MG TABLET UU 60S. The $7,266.08 order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,071 units of the medication XELJANZ XR 11 MG TABLET. The contract has an ultimate completion date of April 11, 2024 and a ceiling value of $8,420.34. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a...